Eric ROUGEMOND, MD, Chief Executive Officer

Eric is also CEO of Laboratoire Aguettant and CEO of PX’Therapeutics. He is a Doctor of Medicine, specialised in Clinical Biology. He was formerly Medical Director at Merck KGaA and OPi, then he was the General Manager (France) and VP of EUSA Pharma. 



Dorothée LEBERT, Chief Scientific Officer

Dorothée is biotech engineer, graduated for ENSTBB. She has an extensive experience in protein production, protein analyses and quantitative proteomics. Dorothée is the author/coauthor of 9 peer-reviewed publications dealing with the development of LC-MS assays for protein quantification in clinical samples.